Skip to main content
Top
Published in: Supportive Care in Cancer 2/2015

01-02-2015 | Original Article

The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study

Authors: Cindy S. Y. Tan, Jane A. Read, Viet H. Phan, Philip J. Beale, Jennifer K. Peat, Stephen J. Clarke

Published in: Supportive Care in Cancer | Issue 2/2015

Login to get access

Abstracts

Background

Malnutrition and elevated inflammatory markers have a negative impact on clinical outcomes in cancer patients. Few studies have investigated the associations between inflammatory makers, nutritional status and survival. This study investigates the association between nutritional status, inflammatory markers and overall survival (OS) in patients with advanced cancer.

Methods

This prospective cohort study recruited 114 adult patients from January 2007 to January 2010. It included patients diagnosed with advanced cancer, good Eastern Cooperative Oncology Group (ECOG) performance status 0–2, a prognosis of more than 3 months and had not received chemotherapy for advanced cancer prior to enrolment. Baseline data were collected prior to commencement of chemotherapy. Patients were followed up from the date of baseline nutritional assessment until the date of death or the date that data were last updated, whichever came first.

Results

Malnourished cancer patients had statistically significant higher concentrations of serum C-reactive protein (CRP), neutrophil-to-lymphocyte ratio (NLR) or modified Glasgow Prognostic Score (mGPS) prior to starting chemotherapy. In univariate analyses to predict survival, mGPS 1 or 2 had a hazard ratio (HR) of 1.81 (95 % confidence interval (CI) 1.13–2.89) and NLR ≥ 5 had a HR of 1.13 (95 % CI 1.08–4.60) and malnutrition (HR of 1.66 for Patient-Generated Subjective Global Assessment (PG-SGA) B (95 % CI 1.02–2.71), and HR for severely malnourished patients (PG-SGA C) was 2.73 (95 % CI 1.50–4.96).

Conclusions

Inflammatory markers were statistically associated with malnutrition. Malnutrition and mGPS were significant independent predictors of overall survival in patients with advanced cancer.
Literature
1.
go back to reference Bozzetti F, On behalf of the Scrinio Working Group (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17(3):279–284PubMedCrossRef Bozzetti F, On behalf of the Scrinio Working Group (2009) Screening the nutritional status in oncology: a preliminary report on 1,000 outpatients. Support Care Cancer 17(3):279–284PubMedCrossRef
2.
go back to reference Read JA, Choy SB, Beale P, Clarke SJ (2006) An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia-Pacific J Clin Oncol 2(2):80–86CrossRef Read JA, Choy SB, Beale P, Clarke SJ (2006) An evaluation of the prevalence of malnutrition in cancer patients attending the outpatient oncology clinic. Asia-Pacific J Clin Oncol 2(2):80–86CrossRef
3.
go back to reference Laky B, Janda M, Cleghorn G, Obermair A (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87(6):1678–1685PubMed Laky B, Janda M, Cleghorn G, Obermair A (2008) Comparison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87(6):1678–1685PubMed
4.
go back to reference Wie G-A, Cho Y-A, Kim S-Y, Kim S-M, Bae J-M, Joung H (2010) Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the national cancer center in Korea. Nutrition (Burbank, Los Angeles County, Calif) 26(3):263–268CrossRef Wie G-A, Cho Y-A, Kim S-Y, Kim S-M, Bae J-M, Joung H (2010) Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the national cancer center in Korea. Nutrition (Burbank, Los Angeles County, Calif) 26(3):263–268CrossRef
5.
go back to reference Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2004) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59(1):35–40CrossRef Gupta D, Lammersfeld CA, Vashi PG, Burrows J, Lis CG, Grutsch JF (2004) Prognostic significance of Subjective Global Assessment (SGA) in advanced colorectal cancer. Eur J Clin Nutr 59(1):35–40CrossRef
6.
go back to reference Gupta D, Lis CG, Vashi PG, Lammersfeld CA (2010) Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 18:373–381PubMedCrossRef Gupta D, Lis CG, Vashi PG, Lammersfeld CA (2010) Impact of improved nutritional status on survival in ovarian cancer. Support Care Cancer 18:373–381PubMedCrossRef
7.
go back to reference Schiesser M, Kirchhoff P, Müller MK, Schäfer M, Clavien P-A (2009) The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery 145(5):519–526PubMedCrossRef Schiesser M, Kirchhoff P, Müller MK, Schäfer M, Clavien P-A (2009) The correlation of nutrition risk index, nutrition risk score, and bioimpedance analysis with postoperative complications in patients undergoing gastrointestinal surgery. Surgery 145(5):519–526PubMedCrossRef
8.
go back to reference Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L (2007) Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26(6):698–709PubMedCrossRef Bozzetti F, Gianotti L, Braga M, Di Carlo V, Mariani L (2007) Postoperative complications in gastrointestinal cancer patients: the joint role of the nutritional status and the nutritional support. Clin Nutr 26(6):698–709PubMedCrossRef
9.
go back to reference Garth AK, Newsome CM, Simmance N, Crowe TC (2010) Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet 23(4):393–401PubMedCrossRef Garth AK, Newsome CM, Simmance N, Crowe TC (2010) Nutritional status, nutrition practices and post-operative complications in patients with gastrointestinal cancer. J Hum Nutr Diet 23(4):393–401PubMedCrossRef
10.
go back to reference Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A (2010) Pretreatment malnutrition and quality of life—association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer 10:232, Epub 2010/05/26PubMedCentralPubMedCrossRef Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A (2010) Pretreatment malnutrition and quality of life—association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer 10:232, Epub 2010/05/26PubMedCentralPubMedCrossRef
11.
go back to reference Arrieta O, Ortega RMM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50PubMedCentralPubMedCrossRef Arrieta O, Ortega RMM, Villanueva-Rodríguez G, Serna-Thomé MG, Flores-Estrada D, Diaz-Romero C et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50PubMedCentralPubMedCrossRef
12.
go back to reference Andreyev H, Norman A, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503–509PubMedCrossRef Andreyev H, Norman A, Oates J, Cunningham D (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies? Eur J Cancer 34(4):503–509PubMedCrossRef
13.
go back to reference Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD (2011) Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr 30(1):92–98PubMedCrossRef Hill A, Kiss N, Hodgson B, Crowe TC, Walsh AD (2011) Associations between nutritional status, weight loss, radiotherapy treatment toxicity and treatment outcomes in gastrointestinal cancer patients. Clin Nutr 30(1):92–98PubMedCrossRef
14.
go back to reference Isenring E, Bauer J, Capra S (2003) The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 57(2):305–309PubMedCrossRef Isenring E, Bauer J, Capra S (2003) The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr 57(2):305–309PubMedCrossRef
15.
go back to reference Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA (2006) Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 59:704–709PubMedCrossRef Gupta D, Lis CG, Granick J, Grutsch JF, Vashi PG, Lammersfeld CA (2006) Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 59:704–709PubMedCrossRef
16.
go back to reference Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437, Epub 2009/06/30PubMedCrossRef Capuano G, Gentile PC, Bianciardi F, Tosti M, Palladino A, Di Palma M (2010) Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 18(4):433–437, Epub 2009/06/30PubMedCrossRef
17.
go back to reference Gupta D, Lammersfeld C, Vashi P, Dahlk S, Lis C (2008) Can subjective global assessment of nutritional status predict survival in ovarian cancer? J Ovarian Res 1(1):5PubMedCentralPubMedCrossRef Gupta D, Lammersfeld C, Vashi P, Dahlk S, Lis C (2008) Can subjective global assessment of nutritional status predict survival in ovarian cancer? J Ovarian Res 1(1):5PubMedCentralPubMedCrossRef
18.
go back to reference Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69(4):491–497PubMedCrossRef Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69(4):491–497PubMedCrossRef
19.
go back to reference Read JA, Choy STB, Beale PJ, Clarke SJ (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55(1):78–85PubMedCrossRef Read JA, Choy STB, Beale PJ, Clarke SJ (2006) Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer 55(1):78–85PubMedCrossRef
20.
go back to reference Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785PubMedCrossRef Bauer J, Capra S, Ferguson M (2002) Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr 56:779–785PubMedCrossRef
21.
go back to reference McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226PubMedCrossRef McMillan DC (2009) Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care 12(3):223–226PubMedCrossRef
22.
go back to reference Deans C, Wigmore S (2005) Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8:265–269PubMedCrossRef Deans C, Wigmore S (2005) Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8:265–269PubMedCrossRef
23.
go back to reference McMillan D, Crozier J, Canna K, Angerson W, McArdle C (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881–886CrossRef McMillan D, Crozier J, Canna K, Angerson W, McArdle C (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881–886CrossRef
24.
go back to reference Sharma R, Hook J, Kumar M, Gabra H (2008) Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44(2):251–256PubMedCrossRef Sharma R, Hook J, Kumar M, Gabra H (2008) Evaluation of an inflammation-based prognostic score in patients with advanced ovarian cancer. Eur J Cancer 44(2):251–256PubMedCrossRef
25.
go back to reference Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91(3):181–184PubMedCrossRef Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91(3):181–184PubMedCrossRef
26.
go back to reference Murri AMA, Bartlett JMS, Canney PA, Doughty JC, Wilson C, McMillan DC (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227–230PubMedCentralPubMedCrossRef Murri AMA, Bartlett JMS, Canney PA, Doughty JC, Wilson C, McMillan DC (2006) Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer 94(2):227–230PubMedCentralPubMedCrossRef
27.
go back to reference Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6(5):450–453PubMedCrossRef Glen P, Jamieson NB, McMillan DC, Carter R, Imrie CW, McKay CJ (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6(5):450–453PubMedCrossRef
28.
go back to reference Chua W, Charles KA, Baracos VE, Clarke SJ (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104(8):1288–1295, Epub 2011 Mar 29PubMedCentralPubMedCrossRef Chua W, Charles KA, Baracos VE, Clarke SJ (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104(8):1288–1295, Epub 2011 Mar 29PubMedCentralPubMedCrossRef
29.
go back to reference Kao SCH, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N et al (2010) High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 16(23):5805–5813PubMedCrossRef Kao SCH, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N et al (2010) High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res 16(23):5805–5813PubMedCrossRef
30.
go back to reference McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67(3):257–262, Epub 2008/05/03PubMedCrossRef McMillan DC (2008) An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc 67(3):257–262, Epub 2008/05/03PubMedCrossRef
31.
go back to reference Slaviero KA, Read JA, Clarke SJ, Rivory LP (2003) Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 46(2):148–157PubMedCrossRef Slaviero KA, Read JA, Clarke SJ, Rivory LP (2003) Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 46(2):148–157PubMedCrossRef
32.
go back to reference Read JA, Crockett N, Volker DH, MacLennan P, Choy ST, Beale P et al (2005) Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer 53(1):51–56PubMedCrossRef Read JA, Crockett N, Volker DH, MacLennan P, Choy ST, Beale P et al (2005) Nutritional assessment in cancer: comparing the Mini-Nutritional Assessment (MNA) with the scored Patient-Generated Subjective Global Assessment (PGSGA). Nutr Cancer 53(1):51–56PubMedCrossRef
33.
go back to reference Roxburgh CSDMM, Salmond JMMM, Horgan PGP, Oien KAP, McMillan DCP (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249(5):788–793PubMedCrossRef Roxburgh CSDMM, Salmond JMMM, Horgan PGP, Oien KAP, McMillan DCP (2009) Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg 249(5):788–793PubMedCrossRef
34.
go back to reference Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92(10):1834–1836PubMedCentralPubMedCrossRef Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dagg K, Scott HR (2005) A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer 92(10):1834–1836PubMedCentralPubMedCrossRef
35.
go back to reference Arrieta O, Michel Ortega R, Villanueva-Rodriguez G, Serna-Thome MG, Flores-Estrada D, Diaz-Romero C et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50, Epub 2010/02/23PubMedCentralPubMedCrossRef Arrieta O, Michel Ortega R, Villanueva-Rodriguez G, Serna-Thome MG, Flores-Estrada D, Diaz-Romero C et al (2010) Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 10:50, Epub 2010/02/23PubMedCentralPubMedCrossRef
36.
go back to reference Deans DAC, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S et al (2009) The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100(1):63–69PubMedCentralPubMedCrossRef Deans DAC, Tan BH, Wigmore SJ, Ross JA, de Beaux AC, Paterson-Brown S et al (2009) The influence of systemic inflammation, dietary intake and stage of disease on rate of weight loss in patients with gastro-oesophageal cancer. Br J Cancer 100(1):63–69PubMedCentralPubMedCrossRef
37.
go back to reference Maurício SF, da Silva JB, Bering T, Correia MITD (2013) Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition 29(4):625–629PubMedCrossRef Maurício SF, da Silva JB, Bering T, Correia MITD (2013) Relationship between nutritional status and the Glasgow Prognostic Score in patients with colorectal cancer. Nutrition 29(4):625–629PubMedCrossRef
38.
go back to reference Silva JBD, Maurício SF, Bering T, Correia MITD (2013) The relationship between nutritional status and the Glasgow Prognostic score in patients with cancer of the esophagus and stomach. Nutr Cancer 65(1):25–33PubMedCrossRef Silva JBD, Maurício SF, Bering T, Correia MITD (2013) The relationship between nutritional status and the Glasgow Prognostic score in patients with cancer of the esophagus and stomach. Nutr Cancer 65(1):25–33PubMedCrossRef
39.
go back to reference Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, Onate-Ocana LF et al (2012) Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 64(4):526–534, Epub 2012/04/12PubMedCrossRef Sanchez-Lara K, Turcott JG, Juarez E, Guevara P, Nunez-Valencia C, Onate-Ocana LF et al (2012) Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer 64(4):526–534, Epub 2012/04/12PubMedCrossRef
40.
go back to reference Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H et al (2010) Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28(28):4376–4383, Epub 2010/09/02PubMedCrossRef Martin L, Watanabe S, Fainsinger R, Lau F, Ghosh S, Quan H et al (2010) Prognostic factors in patients with advanced cancer: use of the patient-generated subjective global assessment in survival prediction. J Clin Oncol 28(28):4376–4383, Epub 2010/09/02PubMedCrossRef
Metadata
Title
The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study
Authors
Cindy S. Y. Tan
Jane A. Read
Viet H. Phan
Philip J. Beale
Jennifer K. Peat
Stephen J. Clarke
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2385-y

Other articles of this Issue 2/2015

Supportive Care in Cancer 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine